Can diabetes meds stop heart plaque? new study aims to find out
NCT ID NCT07254572
First seen Jan 04, 2026 · Last updated Jun 02, 2026 · Updated 23 times
Summary
This study compares two newer diabetes drugs, semaglutide and dapagliflozin, against the standard drug metformin in 300 adults with prediabetes and heart artery disease. The goal is to see which drug best slows or reverses plaque buildup in heart arteries over 24 months. Participants must have prediabetes and confirmed coronary artery disease. The results could help guide treatment to prevent heart attacks and strokes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
National Institute of Cardiology, Department of Coronary Artery and Structural Heart Diseases
RECRUITINGWarsaw, Poland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.